Cell-Penetrating Peptide Conjugates for Blood-Brain Barrier Transport
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic and diagnostic molecules struggle to cross the blood-brain barrier (BBB) due to its selective and controlled nature, limiting their effectiveness in treating central nervous system (CNS) pathologies such as Alzheimer's and Parkinson's disease.
Innovation Solution
A novel cell-penetrating peptide (CPP) with a stable alpha-helix structure and positive surface charges, known as the TB peptide, is designed to facilitate the transport of molecules like the 2C5 nanobody and neurotensin across the BBB by forming stable conjugates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional molecules are used to target CNS pathologies, then their biological activity is maintained, but they fail to cross the blood-brain barrier effectively
Solution Approach 1:
The patent introduces a cell-penetrating peptide (CPP) as an intermediary carrier that facilitates the transport of therapeutic molecules across the BBB. The CPP forms a complex with the therapeutic molecule, enabling it to penetrate the BBB through transcytosis while maintaining the molecule's biological activity. This mediator approach directly resolves the contradiction by providing a transport mechanism without compromising the molecule's function.
Solution Approach 2:
The patent creates a composite structure by fusing the CPP sequence (RQRIWFQNRRRSRKIKK) with the therapeutic molecule to form a fusion protein. This composite combines the BBB-penetrating capability of the CPP with the biological activity of the therapeutic molecule, allowing the entire complex to cross the BBB while maintaining therapeutic efficacy.
2Reliability
If molecule size is increased to enhance therapeutic effect, then biological activity improves, but crossing capability through BBB deteriorates
Solution Approach 1:
The CPP acts as a mediator that enables larger therapeutic molecules to cross the BBB. The peptide complex formation allows molecules larger than typical transporters to be shuttled across the BBB via transcytosis, overcoming the size limitation while maintaining therapeutic effect.
Solution Approach 2:
The patent modifies the physical-chemical parameters of the therapeutic molecule by fusing it with the CPP sequence. This changes the molecule's surface properties and size characteristics, enabling it to interact with BBB transport mechanisms and cross the barrier effectively despite its larger size.
3Reliability
If tight junctions are strengthened to improve BBB selectivity, then barrier function improves, but molecule penetration capability deteriorates
Solution Approach 1:
The CPP serves as a mediator that exploits existing transport pathways in the BBB endothelial cells. By forming a complex with the therapeutic molecule, it utilizes transcytosis mechanisms that remain functional even when tight junctions are strengthened, thereby maintaining penetration capability without compromising barrier integrity.
Solution Approach 2:
The patent segments the transport function from the barrier function. The CPP complex handles the penetration task through transcytosis, while the tight junctions maintain barrier integrity. This segmentation allows both functions to operate independently and optimally without interfering with each other.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The TB peptide effectively transports diagnostic and therapeutic molecules across the BBB, enhancing their delivery to the brain, as demonstrated by increased brain penetration and biological activity, particularly for the 2C5 nanobody and neurotensin.
Implementation Method 1
A novel cell-penetrating peptide (CPP) with a stable alpha-helix structure and positive surface charges, known as the TB peptide, is designed to facilitate the transport of molecules like the 2C5 nanobody and neurotensin across the BBB
Data Source
AI summary
A new peptide and its use as a vector for the transport of molecules after conjugation through cellular barriers for the diagnosis, prognosis or treatment of pathologies of the central nervous system (CNS).